19.09.2017 10:00
Munich Cluster for Systems Neurology (SyNergy)
Martin Ingelsson
Uppsala University, Department of Public Health and Caring Sciences, Uppsala County Council, Uppsala University Hospital

Immunotherapy against alpha synuclein as a novel treatment against Parkinson’s disease

Save to my calender: ics

Center for Stroke and Dementia Research, Large Seminar Room 8G U1 155, Feodor-Lynen Str. 17, 81377 Munich

Host: Stefan Lichtenthaler